Clinical Trial Update: Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial by Al-Azhar University is evaluating whether niacin can affect lipoprotein (a) levels and hyperphosphatemia in patients with end-stage renal di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Niacin (nicotinic acid)

Snippet

Sponsor: Al-Azhar University | Conditions: End-stage Renal Disease | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION